Clinical Outcomes and Major Adverse Events in Patients Treated With Physician-Modified Fenestrated and Branched Stent Grafts

ConditionsJuxtarenal Aortic Aneurysm Pararenal Aneurysm Thoracoabdominal Aortic Aneurysm

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity of California, Los Angeles

About this trial

The purpose of this study is to evaluate safety and effectiveness of endovascular treatment of juxtarenal, pararenal and thoracoabdominal aortic aneurysms (with or without iliac artery involvement) using physician-modified stent grafts with a combination of fenestrations and/or branches.

Eligibility criteria

Qualifiers

Older than 75 years of age

Chronic obstructive pulmonary disease

Congestive heart failure

Previous myocardial infarction, coronary stent, or bypass

Disqualifiers

Less than 18 years of age

Unwilling to comply with the follow-up schedule

Inability or refusal to give informed consent by the patient or a legally authorized representative

Pregnant or breastfeeding

Trial design

Treatments tested in this trial

Cook Alpha TX2 Stent Graft, Cook Zenith TX2, and Cook Zenith Fenestrated Stent Graft

Treatment groups

50 Participants

are divided into 3 treatment groups

Sponsors and collaborators

University of California, Los Angeles

Lead sponsor

Source ClinicalTrials.gov